SPAIN is getting its first doses of an American drug to help people with relapsing-remitting multiple sclerosis, which accounts for 80% of MS sufferers. Zeposia
Want to read the Olive Press with ZERO adverts? Click here to become a subscriber today and enjoy 50% off an annual subscription in our special Black Friday sale